HE-S2

HE-S2 is an antibody-drug conjugate that exhibits significant antitumor activity by blocking PD-1/PD-L1 binding and activating TLR7/8 signaling. This dual mechanism promotes a robust immune response, supporting its investigation in immuno-oncology research for both in vitro mechanistic studies and in vivo tumor model evaluations.